Teofilo Raad
Chief Executive Officer at PULMATRIX, INC.
Net worth: - $ as of 2024-04-29
Teofilo Raad active positions
Companies | Position | Start | End |
---|---|---|---|
PULMATRIX, INC. | Director/Board Member | 2019-05-15 | - |
Chief Executive Officer | 2019-05-15 | - | |
President | 2019-06-27 | - | |
Corporate Officer/Principal | 2017-05-02 | 2019-05-15 | |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Chief Executive Officer | - | - |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Director/Board Member | 2020-12-31 | - |
Career history of Teofilo Raad
Former positions of Teofilo Raad
Companies | Position | Start | End |
---|---|---|---|
Option Care Enterprises, Inc. (Connecticut)
Option Care Enterprises, Inc. (Connecticut) Medical/Nursing ServicesHealth Services Option Care Enterprises, Inc. provides home and alternate treatment site infusion services. The firm's home infusion plus services include the clinical management of infusion medicines, nursing support and care coordination. The company was founded in 1991 and is headquartered in Shelton, CT. | Corporate Officer/Principal | 2012-12-31 | 2015-12-31 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 2009-12-31 | 2011-12-31 |
Training of Teofilo Raad
The University of Colorado | Undergraduate Degree |
Thunderbird School of Global Management | Masters Business Admin |
Statistics
International
United States | 8 |
Operational
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PULMATRIX, INC. | Health Technology |
Private companies | 4 |
---|---|
Option Care Enterprises, Inc. (Connecticut)
Option Care Enterprises, Inc. (Connecticut) Medical/Nursing ServicesHealth Services Option Care Enterprises, Inc. provides home and alternate treatment site infusion services. The firm's home infusion plus services include the clinical management of infusion medicines, nursing support and care coordination. The company was founded in 1991 and is headquartered in Shelton, CT. | Health Services |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Health Technology |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Stock Market
- Insiders
- Teofilo Raad
- Experience